Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

TAFA5 Inhibitors

The chemical class known as TAFA5 Inhibitors represents a group of compounds designed to modulate the activity of TAFA5, a TAFA chemokine-like family member known for its involvement in neural processes and neuroinflammatory pathways. The inhibitors in this class are characterized by their diverse mechanisms of action, each aiming to interact with TAFA5 or its associated pathways to influence its functional role in the nervous system. The primary mechanism of these inhibitors involves preventing the activation or interaction of TAFA5 with its potential receptors or binding partners. This can be achieved either through direct antagonism, where the compounds bind to TAFA5 itself, or through indirect methods, such as modulating the signaling pathways and cellular processes in which TAFA5 is involved. These inhibitors are also designed to target the downstream effects of TAFA5 activation, potentially influencing neuroinflammatory responses and neural communication.

In addition to directly targeting TAFA5, some inhibitors in this class act on related pathways, aiming to indirectly control the protein's activity. For instance, by modulating neuroinflammatory pathways, these inhibitors can impact the environment in which TAFA5 operates, thereby influencing its role in the nervous system. Similarly, compounds that affect neural signaling pathways offer a route to indirectly modulate TAFA5's activity, particularly if it is involved in neurotransmission or synaptic plasticity. The development and categorization of TAFA5 Inhibitors are grounded in an advanced understanding of the protein's role and the complex network of interactions it may be involved in. These inhibitors represent a multifaceted approach to exploring and potentially modulating the functions of TAFA5 in the nervous system. Each inhibitor within the TAFA5 Inhibitors class offers a unique approach to influencing TAFA5's activity, reflecting the intricate strategies employed to modulate specific protein functions. The significance of these inhibitors extends beyond their individual mechanisms, contributing to a broader understanding of TAFA5's role in physiological processes, particularly in the context of neural function and neuroinflammatory responses. By providing diverse methods to interact with TAFA5 and its related pathways, these inhibitors serve as critical tools in the study of neurobiology, enhancing our understanding of the complex interactions and functions within the nervous system.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate, an immunosuppressant, could possibly inhibit TAFA5 by modulating immune responses related to neuroinflammatory pathways.

FTY720

162359-56-0sc-202161
sc-202161A
sc-202161B
1 mg
5 mg
25 mg
$33.00
$77.00
$120.00
14
(1)

Fingolimod could possibly inhibit TAFA5 by influencing neuroinflammatory responses through its action on sphingosine 1-phosphate receptors.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB-203580, a p38 MAPK inhibitor, could possibly inhibit TAFA5 by modulating inflammatory signaling pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK Inhibitor II targets the JNK signaling pathway and could possibly inhibit processes involving TAFA5.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone could possibly inhibit TAFA5 by modulating inflammatory responses within the nervous system.

Ibudilast

50847-11-5sc-203080
10 mg
$218.00
1
(1)

Ibudilast affects cytokine pathways and could possibly inhibit TAFA5's role in neuroinflammation.